IST-MEL1 - Cell Line (ID:50020)
| HMS LINCS ID: | 50020 |
| Name: | IST-MEL1 |
| Alternative Names: | |
| LINCS ID: | LCL-1234 |
| Alternative ID: | CLO_0006969 |
| Parent Cell Line: | |
| Reference Source: | Interlab Cell Line Collection (ICLC) HTL01006 |
| Organism: | Homo sapiens |
| Organ: | skin |
| Tissue: | |
| Cell Type: | epithelial-like |
| Details of Cell Type: | |
| Donor Sex: | male |
| Donor Age: | |
| Donor Ethnicity: | |
| Donor Health Status: | |
| Disease: | DOID:1909, malignant melanoma |
| Details of Disease: | |
| Production Details: | |
| Genetic Modification(s): | none |
| Known Mutations: | |
| Citation Information for Mutations: | COSS907172 |
| Verification Reference Profile: | |
| Growth Properties: | adherent |
| Recommended Culture Conditions: | ICLC growth medium: RPMI 1640 + 10% FBS + 2mM L-Glutamine; Freezing medium: Culture medium + 50% FBS + 10% DMSO; Split confluent cultures 1:2-1:4 using trypsin/EDTA; 37C, 5% CO2, mycoplasma negative, HOECHST and PCR |
| Relevant Citations: | |
| Usage Note: | |
| Comments: | |
| Date Publicly Available: | 2012-04-25 |
| Most Recent Update: | 2016-04-04 |
Batch Information for HMSL50020-1:
| HMS LINCS Batch ID: | 50020-1 |
| Provider: | Center for Molecular Therapeutics (CMT; Massachusetts General Hospital) |
| Provider Catalog ID: | MGH-8077 |
| Provider Batch ID: | |
| Source Information: | Obtained by Nathan Moerke (Harvard Medical School) from the Center for Molecular Therapeutics (CMT; Massachusetts General Hospital) (contact: Cyril Benes). CMT previously had obtained the cells from the Wellcome Trust Sanger Institute. |
| Date Received: | |
| HMS QC Outcome: | |
| Transient Modification(s): | |
| Comments: | |
| Date Publicly Available: | 2012-04-25 |
| Most Recent Update: | 2015-06-29 |